new fda ruling on tirzepatide Says Compounded Must Exit the Market The FDA is proposing the

Xerostomia: When Your Mouth Stops Protecting Itself One of the most commonly reportedand most underestimatedoral side effects of GLP-1 therapy is xerostomia, or chronic dry mouth

for weight loss: Wegovy (semaglutide) Wegovy contains the same active ingredient as Ozempic, semaglutide, but at a higher dose (2.4 mg)

Other therapeutic areas that are being heavily studied include kidney disease and cardiovascular disease, which are often comorbid with obesity and/or type 2 diabetes

Not exactly sure what I expected but Kelly was great

Not 10 milligrams

Phase 3 trials swapped out the 8 mg dose for 6 mg and 9 mg doses based on the phase 2 data